These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 7824958)

  • 1. Interaction between glycosaminoglycans, platelets, and leukocytes.
    Cerletti C; Rajtar G; Marchi E; de Gaetano G
    Semin Thromb Hemost; 1994; 20(3):245-53. PubMed ID: 7824958
    [No Abstract]   [Full Text] [Related]  

  • 2. G protein activation and mediator release from human neutrophils and platelets after stimulation with sodium fluoride and receptor-mediated stimuli.
    Brom C; Brom J; König W
    Immunology; 1991 Jul; 73(3):287-92. PubMed ID: 1652553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human blood platelets, PMN leukocytes and their interactions in vitro. Responses to selective and non-selective stimuli.
    Drábiková K; Jancinová V; Nosál R; Danihelová E
    Gen Physiol Biophys; 2000 Dec; 19(4):393-404. PubMed ID: 11409842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction.
    Liao CH; Cheng JT; Teng CM
    Eur J Pharmacol; 2005 Sep; 519(1-2):158-67. PubMed ID: 16112105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoxin and leukotriene production during receptor-activated interactions between human platelets and cytokine-primed neutrophils.
    Fiore S; Romano M; Serhan CN
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():93-6. PubMed ID: 1825593
    [No Abstract]   [Full Text] [Related]  

  • 6. [The role of the leukocytes in the blood-vasal regulation of the blood circulation].
    Gabrielian ES; Akopov SE; Grigorian MR
    Biull Eksp Biol Med; 1989 Jun; 107(6):660-2. PubMed ID: 2790157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of platelet function by polymorphonuclear leukocytes.
    Zatta A; Prosdocimi M; Bertelé V; Bazzoni G; Del Maschio A
    J Lab Clin Med; 1990 Nov; 116(5):651-60. PubMed ID: 2146349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphonuclear leukocyte-platelet interaction: role of P-selectin in thromboxane B2 and leukotriene C4 cooperative synthesis.
    Maugeri N; Evangelista V; Celardo A; Dell'Elba G; Martelli N; Piccardoni P; de Gaetano G; Cerletti C
    Thromb Haemost; 1994 Sep; 72(3):450-6. PubMed ID: 7531878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet enhancement of O2-. responses in stimulated human neutrophils. Identification of platelet factor as adenine nucleotide.
    Ward PA; Cunningham TW; McCulloch KK; Phan SH; Powell J; Johnson KJ
    Lab Invest; 1988 Jan; 58(1):37-47. PubMed ID: 2826882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of EPA and DHA ethylesters on plasma fatty acids and on platelets, PMN and monocytes in healthy volunteers.
    Tremoli E; Mosconi C; Maderna P; Colli S; Stragliotto E; Sirtori CR; Galli C
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():233-6. PubMed ID: 1847768
    [No Abstract]   [Full Text] [Related]  

  • 11. Neutrophil proteases can inactivate human PAR3 and abolish the co-receptor function of PAR3 on murine platelets.
    Cumashi A; Ansuini H; Celli N; De Blasi A; O'Brien PJ; Brass LF; Molino M
    Thromb Haemost; 2001 Mar; 85(3):533-8. PubMed ID: 11307827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of heparin and related glycosaminoglycans (GAGs) on thrombin-induced platelet aggregation and release.
    Cofrancesco E; Colombi M; Manfreda M; Pogliani EM
    Haematologica; 1988; 73(6):471-5. PubMed ID: 3148509
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of glycosaminoglycans on platelet and leucocyte function: role of N-sulfation.
    Rajtar G; Marchi E; de Gaetano G; Cerletti C
    Biochem Pharmacol; 1993 Sep; 46(5):958-60. PubMed ID: 8373448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defibrotide inhibits platelet activation by cathepsin G released from stimulated polymorphonuclear leukocytes.
    Evangelista V; Piccardoni P; de Gaetano G; Cerletti C
    Thromb Haemost; 1992 Jun; 67(6):660-4. PubMed ID: 1509406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of neutrophil adhesion on the size of aggregates formed by agonist-activated platelets.
    Koda M; Banno Y; Naganawa T
    Platelets; 2005 Dec; 16(8):482-91. PubMed ID: 16287615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new prostacyclin analog, KP-10614, inhibits platelet-polymorphonuclear leukocyte interaction and limits experimental infarct size in rat heart.
    Kanayama T; Kimura Y; Mizogami S
    J Pharmacol Exp Ther; 1993 Jul; 266(1):344-9. PubMed ID: 7687292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential binding of platelets to monocytes over neutrophils under flow.
    Ahn KC; Jun AJ; Pawar P; Jadhav S; Napier S; McCarty OJ; Konstantopoulos K
    Biochem Biophys Res Commun; 2005 Apr; 329(1):345-55. PubMed ID: 15721313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Albumin interferes with arachidonate metabolism in platelets and neutrophils.
    Colli S; Maderna P; Caruso D; Stragliotto E; Galli G; Tremoli E
    Eicosanoids; 1989; 2(1):51-7. PubMed ID: 2561259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelets amplify chemotactic peptide-induced changes in F-actin and calcium in human neutrophils.
    Bengtsson T; Grenegård M
    Eur J Cell Biol; 1994 Apr; 63(2):345-9. PubMed ID: 8082658
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of plumbagin on platelet aggregation and platelet-neutrophil interactions.
    Shen Z; Dong Z; Cheng P; Li L; Chen Z; Liu J
    Planta Med; 2003 Jul; 69(7):605-9. PubMed ID: 12898414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.